Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Oscillatory ventilation reduced reintubation risk for preterm infants

Publish date:: April 7, 2019

Key clinical point: Nasal high-frequency oscillatory ventilation (NHFOV) was more effective than nasal continuous positive airway pressure (NCPAP) for avoiding reintubation among preterm infants, particularly among those at 32 weeks gestation or less and those with acute respiratory distress syndrome (ARDS).

Major finding: The reintubation rate was significantly lower among infants treated with NHFOV compared with NCPAP (15.5% vs. 34%, P = .002).

Study details: A trial of 206 preterm infants with RDS and/or ARDS randomized to NHFOV or NCPAP.

Disclosures: The study was supported by the Social Livelihood Program of Chongqing Science and Technology Commission, China. The researchers had no financial conflicts to disclose.

Citation:

Long C et al. Chest. 2019; 155(4): 740-8.

This Week's Must Reads

Annual WCC visits significantly limit asthma worsening,

Does daily inhaler monitoring improve asthma outcomes in children?,

More severe AD correlates with worse sleep health and attention problems in children,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

Shortcomings identified in study of acne videos on TikTok,

Must Reads in Neonatal Medicine

Three genes could predict congenital Zika infection susceptibility,

Nebulized surfactant shows promise in large cohort,

Social factors predicted peripartum depressive symptoms in Black women with HIV,

Small NY study: Mother-baby transmission of COVID-19 not seen,

Zika virus syndrome may adversely affect children normocephalic at birth,